Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Modified recombinant human C-type natriuretic peptide

EU orphan designation number: EU/3/12/1094   
Active ingredient: Modified recombinant human C-type natriuretic peptide
Indication: Treatment of achondroplasia
Sponsor: BioMarin International Limited
Shanbally, Ringaskiddy, County Cork P43 R298, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/01/2013 Orphan designation EMA/OD/149/12 (2013)483 of 24/01/2013
19/02/2016 Change of name and/or address of sponsor
14/02/2019 Transfer of orphan designation EMA/OD/0000003587 (2019)1348 of 12/02/2019